P8IP
PRCT icon

Pier 88 Investment Partners’s Procept Biorobotics PRCT Stock Holding History

Pier 88 Investment Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,200
Closed -$155K – 122
2026
Q1 		$155K Sell
6,200
-1,900
-23% -$53.5K 0.04% 107
2025
Q4 		$255K Sell
8,100
-80
-1% -$2.65K 0.06% 105
2025
Q3 		$292K Hold
8,180
– – 0.05% 106
2025
Q2 		$471K Buy
8,180
+750
+10% +$42.4K 0.09% 92
2025
Q1 		$433K Sell
7,430
-2,000
-21% -$137K 0.08% 88
2024
Q4 		$759K Buy
+9,430
New +$806K 0.15% 59

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pier 88 Investment Partners's PRCT Position: Q2 2026 in Review

Pier 88 Investment Partners sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 6,200 shares — an estimated $155K sold.

Pier 88 Investment Partners first reported a position in PRCT in Q4 2024 and held it in 6 quarters. The position peaked at $759K in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Pier 88 Investment Partners reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Pier 88 Investment Partners sold 6,200 Procept Biorobotics shares in Q2 2026, an estimated $155K.
  • Pier 88 Investment Partners first reported a position in Procept Biorobotics in Q4 2024 and held it in 6 quarters.
  • Pier 88 Investment Partners's Procept Biorobotics position peaked at $759K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Pier 88 Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.